600572.SH
Zhejiang Conba Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.14
−0.72%Oct 14, 2026, 14:19 UTC
Fenda Technology and eight other A-share listed companies disclosed plans to reduce holdings, while JoulWatt disclosed a plan to increase holdings.
Source:Oct 8, 2026, 08:48 UTC
China's National Medical Products Administration approved Hangzhou CONBA's 30 mg and 60 mg dapoxetine hydrochloride tablets and issued drug registration certificates.
Source:Jul 24, 2026, 08:06 UTC
Conba Group's wholly-owned subsidiary Inner Mongolia Conba received clinical trial approval from the National Medical Products Administration for a new indication of Shexiang Tongxin Dropping Pills.
Source: